866-997-4948 (US-Canada Toll Free)

Stem Cells Market (Adult, Human Embryonic, Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

Published By :

Transparency

Published Date : 2013-06-26

Category :

Medical Equipments

No. of Pages : 115

Product Synopsis

Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells. This report estimates the market for global stem cells in terms of revenue (USD billion) for the period 2012 – 2018, keeping 2011 as the base year. The global stem cells market is mainly segmented into four major sub-types namely market by products, market by technology, market by applications and market by geography. The market by products is segmented into three sub-types, namely adult stem cells, human embryonic stem cells and other type of stem cells. Adult stem cells are further segmented into hematopoietic stem cells, mesenchymal stem cells, neuronal... Read More

Table Of Content

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
3.1.1 Global Stem Cells Market, 2010 – 2018 (USD Billion)
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Unmet Medical Needs
3.2.1.2 Increasing Government Support
3.2.1.3 Growing Medical Tourism
3.2.1.4 Rising Stem Cells Banking Services
3.2.1.5 Impact Analysis of the Market Drivers
3.2.2 Market Restraints
3.2.2.1 High Cost of Treatment
3.2.2.2 Government Regulations against Unethical Harvesting of Stem Cells
3.2.2.3 Impact Analysis of the Market Restraints
3.2.3 Market Opportunities
3.2.3.1 Rising Neurodegenerative Disease Patients
3.2.3.2 Increasing Disposable Income in Emerging Nations
3.2.3.3 Replacing Animal Tissue in Drug Discovery
3.2.3.4 Growing Contract Research Industry
3.2.4 Porter’s Five Forces Analysis for the Global Stem Cells Market
3.2.4.1 Bargaining Power of Suppliers
3.2.4.2 Bargaining Power of Buyers
3.2.4.3 Threat of New Entrants
3.2.4.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness
3.3.1 Market Attractiveness Analysis of the Global Stem Cells Market, By Geography

Chapter 4 Global Stem Cells Market, By Products
4.1 Market Segmentation: Global Stem Cells Market, By Products
4.2 Overview
4.3 Adult Stem Cells Market, 2010 – 2018 (USD Billion)
4.3.1 Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)
4.3.2 Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)
4.3.3 Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)
4.3.4 Dental Stem Cells (Mesenchymal Stem Cells, Neuronal Stem Cells) Market, 2010 – 2018 (USD Billion)
4.3.5 Umbilical Cord Stem Cells (Hematopoietic Stem Cells, Mesenchymal Stem Cells) Market, 2010 – 2018 (USD Billion)
4.4 Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)
4.5 Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)
4.6 Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)
4.7 Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)

Chapter 5 Global Stem Cells Market, By Technology
5.1 Market Segmentation: Global Stem Cells Market, By Technology
5.2 Overview
5.3 Global Stem Cell Acquisition Market, 2010 – 2018 (USD Billion)
5.3.1 Global Bone Marrow Harvest for Stem Cells, 2010 – 2018 (USD Billion)
5.3.2 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)
5.3.3 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)
5.4 Global Stem Cell Production Market, 2010 – 2018 (USD Billion)
5.4.1 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)
5.4.2 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)
5.4.3 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)
5.4.4 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)
5.5 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)
5.6 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)

Chapter 6 Global Stem Cells Market, By Application
6.1 Market Segmentation: Global Stem Cells Market, By Application
6.2 Overview
6.3 Global Stem Cells Market in Regenerative Medicine, 2010 – 2018 (USD Billion)
6.3.1 Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)
6.3.2 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)
6.3.3 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)
6.3.4 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)
6.3.5 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)
6.3.6 Global Stem Cells Market for Injuries, 2010 – 2018 (USD Billion)
6.3.6.1 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)
6.3.6.2 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)
6.3.6.3 Global Stem Cells Market for Other (Joint Injuries, Eye Injuries, Lacerations and Concussions) Injuries, 2010 – 2018 (USD Billion)
6.3.7 Global Stem Cells Market for Diabetes, 2010 – 2018 (USD Billion)
6.3.8 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)
6.3.9 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)
6.3.10 Global Stem Cells Market for Other (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder) Regenerative Medicine Applications, 2010 – 2018 (USD Billion)
6.4 Global Stem Cells Market in Drug Discovery and Development, 2010 – 2018 (USD Billion)

Chapter 7 Global Stem Cells Market, By Geography
7.1 Overview
7.2 North America
7.2.1 North America Stem Cells Market, 2010–2018 (USD Billion)
7.3 Europe
7.3.1 Europe Stem Cells Market, 2010–2018 (USD Billion)
7.4 Asia
7.4.1 Asia Stem Cells Market, 2010–2018 (USD Billion)
7.5 Rest of the World (Row)
7.5.1 Row Stem Cells Market, 2010–2018 (USD Billion)

Chapter 8 Competitive Landscape
8.1 Heat Map Analysis for the Key Market Players
8.1.1 Advanced Cell Technology Inc.
8.1.2 STEMCELL Technologies Inc.
8.1.3 Cellular Engineering Technologies Inc.
8.1.4 Biotime Inc.
8.1.5 Cellartis AB
8.2 Business Strategies for Success
8.2.1 Focus on Research and Development
8.2.2 Partnerships, Collaborations and Acquisitions

Chapter 9 Company Profiles
9.1 Advanced Cell Technology
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Business Strategies
9.1.4 Product Portfolio
9.1.5 Recent Developments
9.2 Angel Biotechnology
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Business Strategies
9.2.4 Product Portfolio
9.2.5 Recent Developments
9.3 Bioheart
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Brainstorm Cell Therapeutics
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Business Strategies
9.4.4 Product Portfolio
9.4.5 Recent Developments
9.5 California Stem Cell Inc.
9.5.1 Company Overview
9.5.2 Product Portfolio
9.5.3 Business Strategies
9.5.4 Recent Developments
9.6 Celgene Corporation Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Business Strategies
9.6.4 Product Portfolio
9.6.5 Recent Developments
9.7 Cellartis AB
9.7.1 Company Overview
9.7.2 Business Strategies
9.7.3 Product Portfolio
9.7.4 Recent Developments
9.8 Cellular Engineering Technologies
9.8.1 Company Overview
9.8.2 Business Strategies
9.8.3 Product Portfolio
9.8.4 Recent Developments
9.9 Cytori Therapeutics Inc.
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Biotime Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Osiris Therapeutics
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Stemcelltechnologies Inc.
9.12.1 Company Overview
9.12.2 Financial Overview
9.12.3 Business Strategies
9.12.4 Product Portfolio
9.12.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Stem Cells Market
TABLE 2 Global Stem Cells Market, By Products, 2010 – 2018 (USD Billion)
TABLE 3 Impact Analysis of the Market Drivers for Stem Cells Market
TABLE 4 Impact Analysis of the Market Restraints for Stem Cells Market
TABLE 5 Global Adult Stem Cells Market, By Products, 2010 – 2018 (USD Billion)
TABLE 6 Global Stem Cells Market, By Technology, 2010 – 2018 (USD Billion)
TABLE 7 Global Cell Acquisition Market, By Procedure, 2010 – 2018 (USD Billion)
TABLE 8 Global Stem Cells Market In Regenerative Medicine, By Applications, 2010 – 2018 (USD Billion)
TABLE 9 Global Stem Cells Market for Injuries, By Applications, 2010 – 2018 (USD Billion)
TABLE 10 Global Stem Cells Market, By Geography, 2010–2018 (USD Billion)

List of Figures


FIG. 1 Global Stem Cells Market, By Product Types, 2011 (USD Billion)
FIG. 2 Global Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 3 Porter’s Five Forces Analysis for the Global Stem Cells Market
FIG. 4 Market Attractiveness Analysis of the Stem Cells Market, By Geography
FIG. 5 Market Segmentation: Global Stem Cells Market, By Products
FIG. 6 Comparative Analysis of The Stem Cells Market, By Products, 2011 & 2018 (%)
FIG. 7 Comparative Analysis of Adult Stem Cells Market, By Products, 2011 & 2018 (%)
FIG. 8 Global Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 9 Global Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 10 Global Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 11 Global Dental Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 12 Global Umbilical Cord Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 13 Global Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 14 Global Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 15 Global Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 16 Global Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 17 Market Segmentation: Global Stem Cells Market, By Technology
FIG. 18 Comparative Analysis of the Global Stem Cells Market, By Technology, 2011 & 2018 (%)
FIG. 19 Comparative Analysis of the Global Cell Acquisition Market, By Procedure, 2011 & 2018 (%)
FIG. 20 Global Bone Marrow Harvest for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 21 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 22 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)
FIG. 23 Comparative Analysis of the Stem Cell Production Market, By Procedures, 2011 & 2018 (%)
FIG. 24 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 25 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)
FIG. 26 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)
FIG. 27 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)
FIG. 28 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)
FIG. 29 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)
FIG. 30 Market Segmentation: Global Stem Cells Market, By Application
FIG. 31 Comparative Analysis of the Global Stem Cells Market, By Application, 2011 & 2018 (%)
FIG. 32 Comparative Analysis of Global Stem Cells Market in Regenerative Medicine, By Applications, 2011 & 2018 (%)
FIG. 33 Global Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)
FIG. 34 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)
FIG. 35 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)
FIG. 36 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)
FIG. 37 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)
FIG. 38 Comparative Analysis of Global Stem Cells in Injuries Market, 2011 & 2018 (%)
FIG. 39 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)
FIG. 40 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)
FIG. 41 Global Stem Cells Market for Other Injuries, 2010 – 2018 (USD Billion)
FIG. 42 Global Stem Cells in Diabetes Market, 2010 – 2018 (USD Billion)
FIG. 43 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)
FIG. 44 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)
FIG. 45 Global Stem Cells Market for Other Regenerative Medicine Applications, 2010 – 2018 (USD Billion)
FIG. 46 Global Stem Cells in Drug Discovery and Development Market, 2010 – 2018 (USD Billion)
FIG. 47 Comparative Analysis of the Global Stem Cells Market, By Geography, 2011 & 2018 (%)
FIG. 48 North America Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 49 Europe Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 50 Asia Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 51 Row Stem Cells Market, 2010 –2018 (USD Billion)
FIG. 52 Heat Map Analysis: Global Stem Cells Market
FIG. 53 Annual Sales of Advanced Cell Technology, 2009 – 2011 (USD Million)
FIG. 54 Annual Revenue of Angel Biotechnology, 2009 – 2011 (USD Million) (Conversion Rate: 1 GBP =1 .52 USD)
FIG. 55 Annual Sales of Bioheart Inc., 2009 – 2011 (USD)
FIG. 56 Annual Revenue of Celgene Corporation Inc., 2009 – 2011 (USD Million)
FIG. 58 Annual Sales of Biotime Inc, 2009 – 2011 (USD Million)
FIG. 60 Annual Sales of Neostem Inc., 2009 – 2011 (USD Million)

Make an enquiry before buying this Report

Please fill the enquiry form below.

Full Name * Message
Your Email *
Job Title
Phone No. * (Pls. Affix Country Code) Security Code *

Upcoming Reports

  • Intravenous Immunoglobulin (IVIG) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    By - Transparency

    Intravenous immunoglobulin (IVIG)is a blood product administered intravenously. These are mainly used for the treatment of immune deficiencies, autoimmune diseases and acute infections. IVIG is given as a plasma protein replacement therapy for immune deficient patients (i.e. patients have decreased or abolished antibody productions). Intravenous immunoglobulin is administered to maintain sufficient antibody levels of a patient in order to prevent infections or to enhance immunity. There are different intravenous immunoglobulinproducts availableas trade names in the market namely Gamunex,...

  • Poland: quartz market

    By - Williams and Marshal Strategy

    This report presents a comprehensive overview of the quartz market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the quartz market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...

  • Nano-Particle Size Analysis Instrumentation in the Life Sciences Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

    By - Transparency

    Nano-particles are defined as small objects, having nanometer size in the range of 1-100 nano-meters. These particles can be divided into different types such as ultrafine particles, coarse particles and fine particles according to their diameters. Nano-particle based analysis instrument are commonly used to detect the diameter of the nano-particles. There are two methods commonly used for detecting or analyzing nano-particle size namely by microscopic techniques and by utilizing relation between particle behavior and its size. The particle size analysis of nano-particles can be...